PERSPECTA

News from every angle

← Back to headlines

Simulations Plus Inc's AI Vision for Drug Development

Simulations Plus Inc (SLP) outlines its strategic vision for integrating artificial intelligence into the drug development process.

19 Apr, 20:51 — 19 Apr, 20:51
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual1h ago

Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development

Read full article →

Related Stories

Four Explanations for 'Unexplained Fatigue'

16m ago

Shreveport Shooter Shamar Elkins' Mental Health Questioned After Fatal Incident

22m ago

Eli Lilly Nears $2 Billion Deal for Kelonia to Expand Cancer Pipeline

23m ago

Advanced Tests for Heart Disease Risk Beyond Cholesterol

31m ago